Maria V. Chirou-Niklison
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status.
Journal: Biology direct
Published: March 11, 2026
Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities.
Journal: Cell death discovery
Published: January 20, 2026
Lipidome atlas of p53 mutant variants in pancreatic cancer.
Journal: Biology direct
Published: January 28, 2025
Simvastatin suppresses spinal cord metastasis of medulloblastoma at clinically significant doses.
Journal: Cell death & disease
Published: July 22, 2024
The Proteasome Inhibitor CEP-18770 Induces Cell Death in Medulloblastoma.
Journal: Pharmaceutics
Published: March 20, 2024
Are lipid droplets the picnic basket of brain tumours?
Journal: Cell death discovery
Published: August 09, 2023
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Journal: Cell death and differentiation
Published: January 30, 2023
The role of immunomodulators in treatment-resistant depression: case studies.
Journal: Cell death discovery
Published: June 23, 2022
Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups.
Journal: Cancers
Published: December 04, 2021
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation.
Journal: Cell death & disease
Published: February 17, 2021
Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?
Journal: Cell death discovery
Published: February 08, 2021
Last Updated: 09/26/2026